
CPHI Milan 2026
10/2026 – 10/2026
GP Pharm is a privately owned pharmaceutical company focused on developing and manufacturing peptide-based injectable products, specializing in sustained-release systems such as microspheres and liposomes. Vertically integrated, the company manages drug development from R&D through market, marketing via its own network in Spain and through global partners in more than 40 countries via out-licensing, and offers CDMO services to third-party companies as a widely GMP-approved manufacturer.

No hay comentarios disponibles.
Deja tu valoración & comentario